Axalta (AXTA) Q2 2026 earnings review

Growth Returns, But M&A Costs Mask the Baseline

Axalta successfully snapped a four-quarter streak of revenue contraction, posting 3% YoY top-line growth to $1.35 billion in Q2. The underlying operational narrative is strong: aggressive cost control and pricing discipline drove Adjusted EBITDA to a record $305 million (22.7% margin) and Adjusted EPS up 13% to $0.72. However, the surface-level GAAP metrics look far less impressive. Net income plummeted 19% YoY to $89 million as the company absorbed $31 million in incremental costs for the pending AkzoNobel merger. With North American volumes still dragging, the earnings beat was engineered entirely through pricing, mix, and efficiency rather than broad-based volume recovery.

๐Ÿ‚ Bull Case

Refinish Destocking Headwinds Clear

Refinish sales rebounded sharply, growing 6% YoY to $545 million. This signals that the painful North American distributor destocking cycle that plagued FY25 is officially in the rearview mirror.

Margin Expansion Masterclass

The 'A Plan' cost actions are bearing fruit. Performance Coatings expanded its Adjusted EBITDA margin by 130 basis points to 25.1%, proving the company can squeeze more profit out of a mixed volume environment.

๐Ÿป Bear Case

North America Volume Erosion

Despite top-line growth, organic volume in North America declined across both Refinish and Industrial segments, indicating sustained macro pressure that price hikes are currently masking.

Mobility Profit Compression

Mobility segment Adjusted EBITDA dropped 5% YoY to $87 million. The lack of operating leverage here highlights a vulnerability if global automotive production slows further.

โš–๏ธ Verdict: ๐ŸŸข

Bullish. The core business is firing on all cylinders regarding cost control and pricing power. While GAAP net income looks ugly due to AkzoNobel merger expenses, the 13% jump in Adjusted EPS and 22.7% margins show robust underlying health.

Key Themes

DRIVER ๐ŸŸข

Performance Coatings Margin Explosion

The Performance Coatings segment was the undisputed engine this quarter. Adjusted EBITDA grew 10% YoY to $218 million, driving margins to a stellar 25.1% (up from 23.8% a year ago). Management achieved this via lower variable and operating expenses combined with a favorable price mix, effectively mitigating the localized volume weakness in North America.

DRIVER ๐ŸŸข

Refinish Resurgence and Tech Adoption

Refinish sales surged 6% YoY to $545 million, confirming the end of the severe destocking headwinds. Growth is being bolstered by strategic rollouts of the Nimbus digital platform and IRIS mixing technology, alongside market share gains in the mainstream and economy tiers (via the CoverFlexx integration), which broadens the addressable market beyond premium shops.

DRIVER โšช

Commercial Vehicle Defies the Macro Cycle

While broader Class 8 truck build data has indicated double-digit market declines for several quarters, Axalta's Commercial Vehicle net sales increased 7% YoY. This showcases the success of the company's diversification into Commercial Transportation Solutions (CTS), allowing them to outgrow a shrinking core market.

CONCERN NEW ๐Ÿ”ด

Mobility Segment Breaks the Margin Narrative

While management touted a 'record quarter for Adjusted EBITDA... demonstrating the earnings power of our business model', the Mobility Coatings segment tells a contradictory story. Despite 1% revenue growth to a record $474 million, segment Adjusted EBITDA actually declined 5% YoY to $87 million, compressing margins to 18.4%. Management cited the non-repeat of favorable one-time items from 25Q2, but this drop exposes a lack of underlying operating leverage in this specific segment.

CONCERN ๐Ÿ”ด

Stubborn North American Volume Weakness (Macro)

Axalta is using pricing to paper over structural volume cracks in North America. Both the Refinish and Industrial divisions reported lower NA volumes. With higher-for-longer interest rates continuing to suppress broader industrial activity and auto accident claim frequencies, the region relies entirely on price-mix expansion to stay afloat.

THEME NEW ๐Ÿ”ด

Merger Costs Eat the Bottom Line

The highly anticipated AkzoNobel merger is racking up a massive pre-closing bill. Axalta reported $35 million in pre-tax M&A costs this quarter (up from just $4 million a year ago). This caused GAAP Net Income to fall 19% to $89 million despite the operational outperformance. Investors must monitor these integration costs, as they will heavily distort GAAP profitability until the deal closes.

Other KPIs

Free Cash Flow $107 million

Accelerating. Up 6% YoY from $101 million in 25Q2. The improvement was driven by disciplined working capital management and lower interest payments, remarkably overcoming the cash drag from the $35 million in M&A costs.

Total Net Leverage Ratio 2.2x

Stable/Improving. Down from 2.5x a year ago and 2.3x at the end of Q1, marking the lowest leverage level in the company's history. This rapid deleveraging perfectly positions the balance sheet ahead of the AkzoNobel merger.

Guidance

Q3 2026 Adjusted EBITDA $295 - $305 million

Stable. The midpoint of $300 million implies approximately 2% YoY growth compared to the $294 million delivered in 25Q3. It reflects sustained momentum but acknowledges a normalized run-rate heading into the back half of the year.

FY 2026 Adjusted EBITDA $1,140 - $1,170 billion

Stable. Management maintained the full-year target. The midpoint of $1.155 billion implies a 2.4% YoY increase from FY25's $1.128 billion. Given the record Q2 beat, keeping the full-year guidance unchanged suggests management may be baking in a cautious macro buffer for H2.

Q3 2026 Adjusted Diluted EPS ~$0.70

Accelerating. Implies a healthy 4.5% YoY growth against the $0.67 delivered in 25Q3, buoyed by the structural drop in interest expenses following the aggressive debt paydowns.

FY 2026 Adjusted Diluted EPS $2.55 - $2.70

Stable. The midpoint of $2.625 represents a ~5.4% YoY increase from the $2.49 reported in FY25. Lower interest expenses ($150 million guided vs $176 million in FY25) act as the primary tailwind here.

Key Questions

Mobility Margins Ex-Items

Mobility Adjusted EBITDA declined 5% YoY despite revenue growth, with management pointing to the non-repeat of 25Q2 one-time benefits. What is the true normalized margin baseline for Mobility today, and how much raw material inflation is currently bleeding through the 50% of contracts subject to indexing lags?

North America Volume Inflection

You noted organic volume declines in North America for both Refinish and Industrial. At what point does pricing exhaustion set in, and what specific leading indicators will signal a return to actual volume growth in this region?

AkzoNobel Integration Spend

With $35 million in M&A costs hitting Q2 alone, what is the expected cash burn for integration and advisory fees through the remainder of the year leading up to the transaction close?